Annual Total Liabilities
$3.28 M
+$582.80 K+21.61%
December 31, 2023
Summary
- As of February 7, 2025, ENTO annual total liabilities is $3.28 million, with the most recent change of +$582.80 thousand (+21.61%) on December 31, 2023.
- During the last 3 years, ENTO annual total liabilities has fallen by -$12.28 million (-78.92%).
- ENTO annual total liabilities is now -83.27% below its all-time high of $19.61 million, reached on December 1, 2021.
Performance
ENTO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$15.77 M
+$284.70 K+1.84%
September 1, 2024
Summary
- As of February 7, 2025, ENTO quarterly total liabilities is $15.77 million, with the most recent change of +$284.70 thousand (+1.84%) on September 1, 2024.
- Over the past year, ENTO quarterly total liabilities has increased by +$12.49 million (+380.76%).
- ENTO quarterly total liabilities is now -19.59% below its all-time high of $19.61 million, reached on December 1, 2021.
Performance
ENTO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ENTO Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.6% | +380.8% |
| 3 y3 years | -78.9% | +459.0% |
| 5 y5 years | +9.5% | +153.0% |
ENTO Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -83.3% | +21.6% | -19.6% | +495.4% |
| 5 y | 5-year | -83.3% | +21.6% | -19.6% | +495.4% |
| alltime | all time | -83.3% | +21.6% | -19.6% | +495.4% |
Entero Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.77 M(+1.8%) |
| Jun 2024 | - | $15.49 M(+16.7%) |
| Mar 2024 | - | $13.27 M(+304.5%) |
| Dec 2023 | $3.28 M(+21.6%) | $3.28 M(+23.9%) |
| Sep 2023 | - | $2.65 M(-23.1%) |
| Jun 2023 | - | $3.45 M(+22.1%) |
| Mar 2023 | - | $2.82 M(+4.6%) |
| Dec 2022 | $2.70 M(-86.2%) | - |
| Dec 2022 | - | $2.70 M(-61.0%) |
| Sep 2022 | - | $6.93 M(-61.8%) |
| Jun 2022 | - | $18.12 M(+0.3%) |
| Mar 2022 | - | $18.07 M(-7.9%) |
| Dec 2021 | $19.61 M(+26.0%) | $19.61 M(+1.1%) |
| Sep 2021 | - | $19.39 M(+187.7%) |
| Jun 2021 | - | $6.74 M(+88.2%) |
| Mar 2021 | - | $3.58 M(-77.0%) |
| Dec 2020 | $15.56 M | $15.56 M(+485.8%) |
| Sep 2020 | - | $2.66 M(-65.3%) |
| Jun 2020 | - | $7.66 M(+48.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $5.14 M(+20.0%) |
| Dec 2019 | $4.29 M(+43.1%) | $4.29 M(-31.3%) |
| Sep 2019 | - | $6.23 M(-6.5%) |
| Jun 2019 | - | $6.66 M(+6.7%) |
| Mar 2019 | - | $6.24 M(+108.4%) |
| Dec 2018 | $3.00 M(-21.6%) | $3.00 M(-1.7%) |
| Sep 2018 | - | $3.05 M(-25.9%) |
| Jun 2018 | - | $4.11 M(-0.9%) |
| Mar 2018 | - | $4.15 M(+8.6%) |
| Dec 2017 | $3.82 M(+7.9%) | $3.82 M(-5.5%) |
| Sep 2017 | - | $4.04 M(-1.9%) |
| Jun 2017 | - | $4.12 M(+4.2%) |
| Mar 2017 | - | $3.95 M(+11.6%) |
| Dec 2016 | $3.54 M(-65.7%) | $3.54 M(-80.3%) |
| Sep 2016 | - | $17.95 M(+13.5%) |
| Jun 2016 | - | $15.81 M(+34.8%) |
| Mar 2016 | - | $11.73 M(+13.7%) |
| Dec 2015 | $10.32 M(+162.4%) | $10.32 M |
| Dec 2014 | $3.93 M | - |
FAQ
- What is Entero Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Entero Therapeutics?
- What is Entero Therapeutics annual total liabilities year-on-year change?
- What is Entero Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Entero Therapeutics?
- What is Entero Therapeutics quarterly total liabilities year-on-year change?
What is Entero Therapeutics annual total liabilities?
The current annual total liabilities of ENTO is $3.28 M
What is the all time high annual total liabilities for Entero Therapeutics?
Entero Therapeutics all-time high annual total liabilities is $19.61 M
What is Entero Therapeutics annual total liabilities year-on-year change?
Over the past year, ENTO annual total liabilities has changed by +$582.80 K (+21.61%)
What is Entero Therapeutics quarterly total liabilities?
The current quarterly total liabilities of ENTO is $15.77 M
What is the all time high quarterly total liabilities for Entero Therapeutics?
Entero Therapeutics all-time high quarterly total liabilities is $19.61 M
What is Entero Therapeutics quarterly total liabilities year-on-year change?
Over the past year, ENTO quarterly total liabilities has changed by +$12.49 M (+380.76%)